Additionally, the underexpression of Olfactomedin-4 (OLFM4), Ectonucleotide Pyrophosphatase/Phosphodiesterase (ENPP), or nucleic acid-associated proteins was observed to increase the cancer risk in these patients [59]. This evidence concerns the gene OLFM4 and cancer.